Birkerod, Denmark

Carsten Jessen

This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignee: Neurosearch A/s. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Jessen. Retrieved from https://idiyas.com/inventor/carsten-jessen-xudml7kq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carsten Jessen: Innovator in Medical Chemistry

Introduction

Carsten Jessen is a notable inventor based in Birkerød, Denmark. He has made significant contributions to the field of medical chemistry, particularly through his innovative work on 2,3-diamino-quinazolinone derivatives. His research focuses on the medical applications of these compounds, which have the potential to treat various disorders.

Latest Patents

Carsten Jessen holds a patent for 2,3-diamino-quinazolinone derivatives and their medical use. This invention provides 2,3-diamino-quinazolinone compounds of Formula (I), including stereoisomers, pharmaceutically-acceptable addition salts, and N-oxides. The compounds have demonstrated medical utility and can be utilized in the manufacture of medicaments, including pharmaceutical compositions. Furthermore, the invention outlines methods for treating disorders, diseases, or conditions responsive to the activation of K7 channels.

Career Highlights

Carsten Jessen is associated with Neurosearch A/S, where he continues to advance his research and development efforts. His work has contributed to the understanding and application of novel compounds in the medical field.

Collaborations

Some of his notable coworkers include William Dalby Brown and Joachim Demnitz, who have collaborated with him on various projects within the realm of medical chemistry.

Conclusion

Carsten Jessen's innovative work in the development of 2,3-diamino-quinazolinone derivatives showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various medical conditions significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…